| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 09/25/2003 | WO2002044422A3 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits |
| 09/25/2003 | WO2002024690A3 Efficient process for the preparation of a factor xa inhibitor |
| 09/25/2003 | US20030181458 Preferential serotonin receptors antagonists comprising heterocyclic amines used for prophylaxis or prevention of headaches, sleep, sexual or eating disorders and as antidepressants |
| 09/25/2003 | CA2479211A1 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives |
| 09/24/2003 | EP1345942A2 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists |
| 09/24/2003 | EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors |
| 09/24/2003 | EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors |
| 09/24/2003 | EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/24/2003 | EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors |
| 09/24/2003 | EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors |
| 09/24/2003 | EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/24/2003 | CN1444647A Novel probiotics for pet. food applications |
| 09/24/2003 | CN1444584A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 09/24/2003 | CN1444477A Thrombopoietin mimetics |
| 09/24/2003 | CN1444450A Allantoin-containing skin cream |
| 09/24/2003 | CN1121859C Process for preparing pharmaceutical composition for treatment or prevention hypertension |
| 09/23/2003 | US6624292 Methylation of erythromycin A followed by slurrying with water |
| 09/23/2003 | US6624195 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
| 09/23/2003 | US6623739 Oil-in-water emulsions containing metabolizable oil and alpha tocopherol; enhancing immune responses to given antigen |
| 09/23/2003 | CA2139781C Ophthalmic topical composition containing (s)-timolol hemihydrate |
| 09/23/2003 | CA2085781C Bradykinin-antagonists for the treatment of acute pancreatitis |
| 09/18/2003 | WO2003075914A1 Citalopram for the treatment of elevated blood pressure |
| 09/18/2003 | WO2003045392A3 Use of n-(indolcarbonyl-)piperazine derivatives |
| 09/18/2003 | WO2003026584A3 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 09/18/2003 | WO2003024489A3 Combination of a nsaid and a pde-4 inhibitor |
| 09/18/2003 | US20030176701 Di-or triaza-spiro [4,5] decane derivatives |
| 09/18/2003 | US20030176697 Such as 2-(methylsulfanyl)-6-(3,5-dimethyoxyphenyl)-8-ethyl-8H-pyrido(2,3-d) -pyrimidine-7-one; antitumor agents; calcium channel blockers |
| 09/18/2003 | US20030176647 Antibodies to OCIF-binding molecules |
| 09/18/2003 | US20030176332 Novel use of cytokine inhibitors |
| 09/18/2003 | US20030175333 Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin |
| 09/18/2003 | US20030175264 Comprises proteolytic enzymes; free of plasminogen activator |
| 09/18/2003 | US20030172474 Acyl isethionates, acyl taurates, sulphosuccinates, acyl sarcosinates, acyl glutamates, polyoxyalkylenated ether carboxylic acids, fatty glucamide sulphates, alkylgalactoside uronates, anionic derivatives of alkyl polyglucosides |
| 09/18/2003 | CA2459834A1 Citalopram for the treatment of elevated blood pressure |
| 09/17/2003 | EP1343782A1 Pyrimidineamines as angiogenesis modulators |
| 09/17/2003 | EP1343525A2 IMPROVED i MYCOPLASMA HYOPNEUMONIAE /i BACTERIN VACCINE |
| 09/17/2003 | EP1143966B1 Preparation for warts |
| 09/17/2003 | EP0946179B1 Use of olanzapine or a pharmaceutically acceptable salt for the manufacture of a medicament for the treatment of autism and mental retardation |
| 09/17/2003 | EP0941099B1 Treatment of bronchitis with diuridine tetraphosphate |
| 09/17/2003 | EP0768089B1 Hot water extract of Cordyceps sinensis |
| 09/17/2003 | CN1443192A Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 09/17/2003 | CN1443173A Substituted imidazoles as TAFI a inhibitors |
| 09/17/2003 | CN1443168A 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis |
| 09/17/2003 | CN1443069A Sustained release ranolazine formulations |
| 09/17/2003 | CN1121213C Method of preparing sustained release compositions |
| 09/17/2003 | CN1121211C Detergent composition for skin |
| 09/17/2003 | CN1121208C Sunning protecting cosmetic composition based on light filing agent efficiency increasing mixture and use of same |
| 09/16/2003 | US6620847 Copolymer-1 improvements in compositions of copolymers |
| 09/16/2003 | US6620442 Extract of jojoba; simmondsin ferulate may be selectively reduced or removed from the extracts using activated carbon; improves organoleptic property, palatability; feeds |
| 09/16/2003 | CA2309573C Antiperspirant suspensions containing finely divided aluminium and zirconium, having better effectiveness and a process for their manufacture |
| 09/16/2003 | CA2283671C Salt of naphthyridine carboxylic acid derivative |
| 09/12/2003 | WO2003074479A1 Semicarbazide derivatives and their use as antithrombotics |
| 09/12/2003 | WO2003074062A2 Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
| 09/12/2003 | WO2003074036A1 Novel formulation |
| 09/12/2003 | WO2003073981A2 Novel of cytokine inhibitors |
| 09/12/2003 | WO2003006612A3 Production of transduced hematopoietic progenitor cells |
| 09/12/2003 | CA2478528A1 Semicarbazide derivatives and the use thereof as antithrombotics |
| 09/12/2003 | CA2478378A1 Novel use of cytokine inhibitors |
| 09/12/2003 | CA2477785A1 Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
| 09/11/2003 | US20030170320 Extract is composed of carboxy alkyl esters, especially quinic acid lactone. |
| 09/11/2003 | US20030170270 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule. |
| 09/11/2003 | US20030170183 Promotes the release of the active particles from the carrier particles on actuation of the inhaler; efficiency |
| 09/11/2003 | US20030170179 As contrast medium for fluorescence and transillumination diagnostics; drugs |
| 09/10/2003 | EP1181030B1 Tanacetum parthenium extract |
| 09/10/2003 | EP1169044B1 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence |
| 09/10/2003 | EP1156814B1 Pharmaceuticals, dietary supplements and cosmetic compositions comprising a fatty acid and ginger |
| 09/10/2003 | EP1137644B1 Benzofuran derivatives, their preparation and use |
| 09/10/2003 | EP0967957B1 Personal cleansing compositions |
| 09/10/2003 | EP0912570B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/10/2003 | CN1441789A Piperazinedione compounds |
| 09/10/2003 | CN1441671A Fatty acid analogues for treatment of cancer |
| 09/10/2003 | CN1440816A Improvement for diagnosis and/or therapeutic agnet and its relative improvement |
| 09/09/2003 | US6617339 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/09/2003 | US6617336 Treatment of urinary incontinence, venous insufficiency, migraine or gastrointestinal disorders |
| 09/09/2003 | US6617332 Cyclic amidinourea derivatives |
| 09/09/2003 | US6616949 Aqueous solution of biologically active substance is mixed with polyethylene glycol solution;washing concentrated and/or solidified biologically active substance; mixing with solution of biodegradable polymer to emulsify; solidification, drying |
| 09/09/2003 | US6616943 Composition comprising Wenguanguo extracts and methods for preparing same |
| 09/09/2003 | CA2165952C Skin and scalp barrier for use with hair treatment products |
| 09/09/2003 | CA2138026C Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists |
| 09/04/2003 | WO2003072576A2 Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 09/04/2003 | WO2003072139A1 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative |
| 09/04/2003 | WO2003072051A2 Methods of using fet labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same |
| 09/04/2003 | WO2003072040A2 Administration of agents for the treatment of inflammation |
| 09/04/2003 | WO2003039442A3 Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition |
| 09/04/2003 | WO2002046237A3 Humanized antibodies that recognize beta amyloid peptide |
| 09/04/2003 | US20030166935 Spiroazabicyclic heterocyclic compounds |
| 09/04/2003 | US20030166702 Contacting carvedilol and ethyl acetate to form a solution, and cooling the solution whereby a precipitate is formed; hypotensive agent |
| 09/04/2003 | US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 09/04/2003 | US20030166631 Pharmaceutical compositions and methods for administering EP2 receptor selective agonists |
| 09/04/2003 | US20030166617 Combination therapies with vascular damaging activity |
| 09/04/2003 | US20030166238 Recombinant toxin fragments |
| 09/04/2003 | US20030165935 Quantitating target nucleotide sequences using labeled probes; forensics; infection diagnosis; heredity testing; organ transplantation |
| 09/04/2003 | US20030165920 Identifying polymerase chain reaction primer extension products using fluorescence energy transfer (FET); detecting allelic variation/restriction fragment length polymorphisms |
| 09/04/2003 | US20030165496 Alzheimer's disease |
| 09/04/2003 | US20030165435 Using ethanol solvent |
| 09/04/2003 | US20030165352 Method and apparatus for improved stiffness in the linkage assembly of a flexible arm |
| 09/04/2003 | CA2477379A1 Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 09/04/2003 | CA2477178A1 Administration of agents for the treatment of inflammation |
| 09/04/2003 | CA2472554A1 Methods of using fet labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same |
| 09/03/2003 | EP1339678A2 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 09/03/2003 | EP1339420A1 Process for preparing aqueous extracts of plants and extracts so obtained |